Literature DB >> 2017280

Rhabdomyolysis with simvastatin use.

Y Berland, H Vacher Coponat, C Durand, M Baz, R Laugier, J L Musso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2017280     DOI： 10.1159/000186289

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  4 in total

1.  Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.

Authors:  Beatrice A Golomb; Abril Verden; Alexis K Messner; Hayley J Koslik; Keith B Hoffman
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

Review 2.  Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.

Authors:  G L Plosker; D McTavish
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

3.  Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.

Authors:  M D Feher; J Foxton; D Banks; A F Lant; R Wray
Journal:  Br Heart J       Date:  1995-07

4.  Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.

Authors:  S G O'Brien; P Meinhardt; E Bond; J Beck; B Peng; C Dutreix; G Mehring; S Milosavljev; C Huber; R Capdeville; T Fischer
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.